# Jeff Johnson (Robert W. Baird): Analyst Track Record and Price‑Target Accuracy

> How often Jeff Johnson’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 1,096 ratings, compared with the average Wall Street analyst.

Source: https://www.exent.ai/analysts/jeff-johnson · Reviewed by David, Senior Analyst, Exent · Published Nov 9, 2026 · Updated Nov 9, 2026

## Key takeaways

- Jeff Johnson ranks #974 of 1,181 analysts in Exent’s scoring (4.6★).
- 37.8% of price targets were reached over 7 years, versus 53.1% for the average analyst.
- Median time to reach a target: 91 days; 41.1% of calls were up 12 months later.
- Most‑covered stocks: NVST, DXCM, XRAY, INMD.
- Free on Exent: Jeff Johnson’s full record, with ratings 3 days after publication.

## Jeff Johnson’s track record at a glance

Jeff Johnson of [Robert W. Baird](https://www.exent.ai/firms/robert-w-baird) ranks **#974** of the 1,181 analysts Exent scores, with a 4.6★ rating and a focus on [healthcare](https://www.exent.ai/analysts/sectors/healthcare). Over a 7‑year lookback, **37.8%** of Jeff’s price targets were reached, 15.3 points below the 53.1% average across all analysts.

| Metric | Jeff Johnson | All analysts |
| --- | --- | --- |
| Price‑target hit rate | 37.8% | 53.1% |
| Median days to hit target | 91 days | 93 days |
| Calls up after 12 months | 41.1% | 64.4% |
| Median 12‑month return of calls | −8.6% | +13.5% |
| Hit rate, last 2 years | 40.7% | — |
| Average worst drop after a call | −27.5% | — |
| Ratings in the sample | 1,096 | — |
| Stocks covered | 16 | — |

The full records of Exent’s top 50 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in [Exent Gems](https://www.exent.ai/radar).

## How fast price targets were reached

| Time to reach the target | Jeff Johnson |
| --- | --- |
| Under 30 days | 23.4% |
| 30–90 days | 26.5% |
| 90–180 days | 27.0% |
| Over 180 days | 23.1% |

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

## Stocks Jeff Johnson covers most

| Stock | Ratings in the sample |
| --- | --- |
| NVST | 48 |
| [DXCM](https://www.exent.ai/stocks/dxcm) | 41 |
| XRAY | 35 |
| INMD | 31 |
| [ZBH](https://www.exent.ai/stocks/zbh) | 30 |
| ALGN | 29 |
| PODD | 27 |
| TNDM | 27 |

In the past year Jeff’s ratings were 68% Buy, 32% Hold and 0% Sell.

## Exent’s top 50 analysts

Across 983,543 ratings, the average Wall Street analyst’s price target was reached 53.1% of the time: close to a coin flip. The spread between analysts is wide, and 14.3% of the 965 analysts with a measurable record reached 70% or more (Exent data, Nov 9, 2026).

Exent Gems is built on the top 50 of Exent’s ranking. Over the last two years, some of them reached 90% or more of their price targets. Who they are, which stocks they are calling now and how often they have been right is for members.

[Unlock the top 50 analysts](https://www.exent.ai/radar)

## Jeff Johnson’s latest ratings

| Date | Stock | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Nov 6, 2026 | XRAY | Reiterated: Hold | Hold | $9.00 |
| Nov 5, 2026 | [ZBH](https://www.exent.ai/stocks/zbh) | Reiterated: Hold | Hold | $114.00 |
| Nov 5, 2026 | NVST | Reiterated: Hold | Hold | $29.00 |
| Nov 4, 2026 | PODD | Maintained: Buy | Buy | $200.00 |
| Oct 30, 2026 | [SYK](https://www.exent.ai/stocks/syk) | Reiterated: Buy | Buy | $334.00 |
| Oct 15, 2026 | ALGN | Downgraded: Hold | Hold | $162.00 |
| Oct 15, 2026 | NVST | Downgraded: Hold | Hold | $26.00 |
| Oct 9, 2026 | HSIC | Reiterated: Buy | Buy | $109.00 |
| Sep 15, 2026 | BBNX | Reiterated: Hold | Hold | $16.00 |
| Sep 10, 2026 | COO | Downgraded: Hold | Hold | $61.00 |

Jeff’s ratings are free on Exent 3 days after publication. [Exent Gems](https://www.exent.ai/radar) has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

## More analysts to compare

Also at [Robert W. Baird](https://www.exent.ai/firms/robert-w-baird): [Chris O`Cull](https://www.exent.ai/analysts/chris-o`cull) · [Colin Sebastian](https://www.exent.ai/analysts/colin-sebastian) · [Justin Hauke](https://www.exent.ai/analysts/justin-hauke) · [David Koning](https://www.exent.ai/analysts/david-koning) · [William Power](https://www.exent.ai/analysts/william-power) · [Mircea Dobre](https://www.exent.ai/analysts/mircea-dobre)

Also covering [healthcare](https://www.exent.ai/analysts/sectors/healthcare): [Vijay Kumar](https://www.exent.ai/analysts/vijay-kumar) · [Matthew Taylor](https://www.exent.ai/analysts/matthew-taylor) · [Brian Abrahams](https://www.exent.ai/analysts/brian-abrahams) · [Kallum Titchmarsh](https://www.exent.ai/analysts/kallum-titchmarsh) · [Yanan Zhu](https://www.exent.ai/analysts/yanan-zhu) · [Madison Elsaadi](https://www.exent.ai/analysts/madison-elsaadi)

## How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Nov 9, 2026; ranking updated Nov 11, 2026. [How accurate are analyst price targets overall?](https://www.exent.ai/resources/are-analyst-price-targets-accurate)

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

## Follow the analysts with the best records

1. Exent Gems shows live ratings from the top‑ranked analysts, without the 3‑day delay used on this page.
2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product: [Exent Gems](https://www.exent.ai/radar)

## Frequently asked questions

### Is Jeff Johnson a good analyst?

By Exent’s scoring Jeff Johnson ranks #974 of 1,181 with a 4.6★ rating. 37.8% of price targets were reached over a 7-year lookback (all analysts: 53.1%), and 41.1% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

### What is Jeff Johnson’s success rate?

In Exent’s 7-year price-target backtest, 37.8% of Jeff Johnson’s price targets were reached, with a median of 91 days to reach a target (all analysts: 53.1%).

### Which stocks does Jeff Johnson cover?

Jeff Johnson (Robert W. Baird) covers 16 stocks, mostly in healthcare. The most frequently rated are NVST, DXCM, XRAY, INMD, ZBH.

---

Educational content, not investment advice. Past performance does not guarantee future results.